Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of circRNAs in the Development of Heart Failure. | Int J Mol Sci | 2022 | 36430607 | PubTator, text mining | PubMed |
| miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer. | Int J Mol Sci | 2022 | 36430305 | PubTator, text mining | PubMed |
Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections. | Int J Mol Sci | 2022 | 36430232 | PubTator, text mining | PubMed |
| Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes. | Metabolites | 2022 | 36422274 | PubTator, text mining | PubMed |
| The Potential Role of Dysregulated miRNAs in Adolescent Idiopathic Scoliosis and 22q11.2 Deletion Syndrome. | J Pers Med | 2022 | 36422101 | PubTator, text mining | PubMed |
| Association between Sperm Morphology and Altered Sperm microRNA Expression. | Biology (Basel) | 2022 | 36421385 | PubTator, text mining | PubMed |
| Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking. | Front Oncol | 2022 | 36419898 | PubTator, text mining | PubMed |
| MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis. | Front Med (Lausanne) | 2022 | 36419785 | PubTator, text mining | PubMed |
| Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction. | Front Oncol | 2022 | 36408130 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis to explore a robust diagnostic signature and landscape of immune cell infiltration in sarcoidosis. | Front Med (Lausanne) | 2022 | 36405616 | PubTator, text mining | PubMed |
| Recent progress in epigenetics of obesity. | Diabetol Metab Syndr | 2022 | 36397166 | PubTator, text mining | PubMed |
| A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study. | Front Med (Lausanne) | 2022 | 36388933 | PubTator, text mining | PubMed |
| Identification of prognostic miRNA-mRNA regulatory network in the progression of HCV-associated cirrhosis to hepatocellular carcinoma. | Transl Cancer Res | 2022 | 36388056 | PubTator, text mining | PubMed |
| Circular RNAs in diabetes and its complications: Current knowledge and future prospects. | Front Genet | 2022 | 36386812 | PubTator, text mining | PubMed |
| miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential. | Front Pharmacol | 2022 | 36386184 | PubTator, text mining | PubMed |
| HLGNN-MDA: Heuristic Learning Based on Graph Neural Networks for miRNA-Disease Association Prediction. | Int J Mol Sci | 2022 | 36361945 | PubTator, text mining | PubMed |
| Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives. | Cells | 2022 | 36359889 | PubTator, text mining | PubMed |
| Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36358867 | PubTator, text mining | PubMed |
| MicroRNAs' Crucial Role in Salivary Gland Cancers' Onset and Prognosis. | Cancers (Basel) | 2022 | 36358723 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies. | Cancers (Basel) | 2022 | 36358625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=27